FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention describes a novel 1,2,4-trizole compound represented by the general formula (1): 
wherein R2 represents unsubstituted pyridyl or pyridyl substituted with cyano-group, and so on; R1 represents unsubstituted pyridyl, pyridyl substituted with halogen atom, and so on, or phenyl substituted with cyano-group and, so on; R3 represents hydrogen atom or pivaloyloxy-substituted lower alkyl wherein each is bound with one nitrogen atom that is a member of 1,2,4-triazole ring in the general formula (1). Compound is useful as a therapeutic agent against hyperuricemia and gout caused by hyperuricemia. Also, invention describes a medicinal agent designated for inhibition of activity of xanthine oxidase. Also, invention describes method for synthesis of compound of the formula (I).
EFFECT: valuable biochemical and medicinal properties of compounds, improved methods of synthesis.
8 cl, 2 tbl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
| 3-AMINOCYCLOPENTANCARBOXAMIDE DERIVATIVES | 2013 |
|
RU2641913C2 |
| TLR7/8 ANTAGONISTS AND USE THEREOF | 2019 |
|
RU2833035C2 |
| DISCLOSED ARE 6,7-DIHYDRO-5H-PYRIDO[2,3-C]PYRIDAZINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF BCLXL PROTEINS AND PROAPOPTOTIC AGENTS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2832191C2 |
| FURO[3,2-B]- AND THIENO[3,2-B]PYRIDINE DERIVATIVES AS TBK1 AND IKKε INHIBITORS | 2013 |
|
RU2622034C2 |
| SUBSTITUTED COMPOUNDS OF PYRIDINE AZOLOPYRIMIDINE-5-(6H)-ONE | 2013 |
|
RU2653054C2 |
| INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2288228C2 |
| 5-MEMBERED HETEROCYCLIC COMPOUND AND ITS APPLICATION FOR MEDICINAL PURPOSES | 2008 |
|
RU2515968C2 |
| 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
| 10H-PHENOTHIAZINE FERROPTOSIS INHIBITORS, THEIR PRODUCTION METHOD AND THEIR USE | 2019 |
|
RU2787366C2 |
